CCR Translation for This Article from Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
收藏NIAID Data Ecosystem2026-05-16 收录
数据链接：
官方服务：
资源简介：
CCR Translation for This Article from Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
创建时间：
2012-04-01
